Press Releases
 
Focal Segmental Glomerulosclerosis Market to Become Worth US$15.83 bn by 2025

, 13 February 2018 -- Global Focal Segmental Glomerulosclerosis (FSGS) Market: Launch of Pipeline Products in Foreseeable Future to Change Market Dynamics

As per a report by Transparency Market Research, the global focal segmental glomerulosclerosis (FSGS) market will likely rise at a solid 8.0% CAGR over the course of the forecast period from 2017 to 2025. Expanding at this pace, the market which was worth US$7.82 bn in 2016, is projected to attain a value of US$15.83 bn by 2025-end.

Rising Instances of the Rare Disease Boosts Demand in Market

Focal segmental glomerulosclerosis (FSGS) is a type of rare kidney disease that affects the kidney’s filtering system (glomeruli) resulting in proteinuria and serious scarring. Focal segmental glomerulosclerosis (FSGS) is usually fatal since it causes kidney failure within four to nine years followed by dialysis and then death. FSGS advances much more swiftly than diabetic nephropathy. Massive proteinuria, nephrotic syndrome, edema, hyperlipidemia, and hypoalbuminemia are some of the common symptoms of the disease. Risk factors include obesity, infection, sickle cell disease and reflux nephropathy.

View Report Preview at https://www.transparencymarketresearch.com/focal-segmental-glomerulosclerosis-market.html

“Focal segmental glomerulosclerosis affects approximately 210,200 patients worldwide with 14,000 to 16,000 new cases every year. This has been a major growth driver in the market,” explains the lead analyst of the report.

Efforts by NGOs to Generate Awareness about FSGS to Bolster Market

Apart from the rising cases of the medical condition, other factors that can benefit the market are efforts by non-government organizations to increase awareness and increasing allocation towards research on rare diseases. NephCure Kidney International, The Kidney & Urology Foundation of America (KUFA), EURORDIS, and The National Organization for Rare Disorders (NORD) are some of the non-governmental organizations that are helping out patients with focal segmental glomerulosclerosis and generating awareness about the disease. Besides, research in the renal treatment field have resulted in several new drugs being developed and approved every year.

Request to View Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31505

Rising kidney transplants and dialysis procedures are other factors promoting the said market. As per the analyst, the market holds out a lot of opportunity due to a limited number of pipeline products at present.

Based upon the type of disease, the market can be bifurcated into primary focal segmental glomerulosclerosis and secondary focal segmental glomerulosclerosis. Between the two, the primary focal segmental glomerulosclerosis held a substantial 79.8% share in the market in 2016. Growing awareness about the disease and its management is at the forefront of driving growth in the segment.

Download PDF Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31505

Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa are some of the prominent geographic segments in the global focal segmental glomerulosclerosis market. North America, of them, leads with a dominant share on the back of a properly structured healthcare industry and availability of reimbursement policies with wider coverage. The U.S. is mainly serving to drive the market in North America due to the greater uptake of advanced and high-cost drug therapies, considerable penetration of treatment, and helpful reimbursement policies. Another factor stoking market growth in the U.S. is the classification of focal segmental glomerulosclerosis (FSGS) drugs under orphan disease drugs categories.
Some of the key participants in the global market for focal segmental glomerulosclerosis (FSGS) are Variant Pharmaceuticals, Inc., GlaxoSmithKline plc., Novartis AG, ChemoCentryx, Inc., Retrophin, Inc., AbbVie, Inc., AstraZeneca plc., Pfizer, Inc., Sanofi S.A, and Teva Pharmaceutical Industries Ltd.

Buy Focal Segmental Glomerulosclerosis (FSGS) Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=31505<ype=S

The global focal segmental glomerulosclerosis (FSGS) market will likely see continued changes in its contours with the successful launch of pipeline products in the next couple of years.

About TMR
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

# # #


Media Contacts:
Contact
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: http://www.transparencymarketresearch.com
Research Blog: http://theglobalhealthnews.com/

Submitted by Sandy Researcher, Transparency Market Research on Tuesday, 13 February 2018 at 6:49 PM
Category: Health Care & Medical
 
Related News

Polymerase Chain Reaction Market: Emergence of Digital PCR Systems to Boost the Growth
Monday, 22 Oct 2018

Radiopharmaceuticals Market to Expand at a CAGR of 5.4% over 2017-2024
Monday, 22 Oct 2018

Oral Thin Film Drugs Market Size, Application Analysis, Regional Outlook, 2017 - 2025
Monday, 22 Oct 2018

Compression Therapy Market: Increasing Popularity of Sports and Other Activities Boosting Market
Monday, 22 Oct 2018

Large Molecule Injectable Drugs Market Size, Application Analysis, Regional Outlook, 2018 - 2026
Monday, 22 Oct 2018

Related Events

National Family Medicine Board Review
Sunday, 21 Oct 2018

92nd Annual Clinical Reviews 2018
Monday, 22 Oct 2018

2nd Annual NASH Summit Europe
Monday, 22 Oct 2018

Precision CRISPR: Drug Discovery and Gene Therapy London 2018
Monday, 22 Oct 2018

Gene Therapy for Rare Disorders Europe Summit
Monday, 22 Oct 2018

Latest News

Future Electronics Participates in McGill University’s Career Fair in Montreal
Tuesday, 23 Oct 2018

Polymerase Chain Reaction Market: Emergence of Digital PCR Systems to Boost the Growth
Monday, 22 Oct 2018

Radiopharmaceuticals Market to Expand at a CAGR of 5.4% over 2017-2024
Monday, 22 Oct 2018

Oral Thin Film Drugs Market Size, Application Analysis, Regional Outlook, 2017 - 2025
Monday, 22 Oct 2018

The Importance Of A great Hair Salon
Monday, 22 Oct 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 23 October 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • National Family Medicine Board Review
  • CRU Ryan's Notes Ferroalloys Conference 2018, Orlando, Florida, USA
  • American Manufacturing Strategies Summit 2018, San Diego
  • American Supply Chain Management Strategies Summit 2018, San Diego
  • 2nd Annual NASH Summit Europe

  • Latest Jobs
    Sorry, there are currently no entries posted here.